Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,225 | -14,668 | -10,273 | -4,738 | -34,188 |
| Accounts payable and accrued liabilities | 272 | 106 | 494 | 336 | -4,762 |
| Other Working Capital | -1,675 | -176 | 1,201 | 267 | -2,513 |
| Other Operating Activity | 1,133 | 1,154 | 321 | 99 | 24,717 |
| Operating Cash Flow | $-17,495 | $-13,584 | $-8,257 | $-4,036 | $-16,746 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | N/A | -2,155 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 18,292 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $16,137 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113,880 | 14,491 | 4,522 | 4 | 15 |
| Other Financing Activity | 301 | 301 | 301 | 0 | 0 |
| Financing Cash Flow | $114,181 | $14,792 | $4,823 | $4 | $15 |
| Beginning Cash Position | 20,051 | 20,051 | 20,051 | 20,051 | 20,645 |
| End Cash Position | 116,737 | 21,259 | 16,617 | 16,019 | 20,051 |
| Net Cash Flow | $96,686 | $1,208 | $-3,434 | $-4,032 | $-594 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,495 | -13,584 | -8,257 | -4,036 | -16,746 |
| Free Cash Flow | -17,495 | -13,584 | -8,257 | -4,036 | -16,746 |